SORIA, ALESSANDRO
 Distribuzione geografica
Continente #
NA - Nord America 2.882
EU - Europa 1.489
AS - Asia 604
SA - Sud America 42
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 4
Totale 5.027
Nazione #
US - Stati Uniti d'America 2.840
IT - Italia 343
DE - Germania 289
SG - Singapore 254
SE - Svezia 250
IE - Irlanda 203
CN - Cina 144
RU - Federazione Russa 136
HK - Hong Kong 71
GB - Regno Unito 63
UA - Ucraina 56
ID - Indonesia 43
CA - Canada 41
IN - India 36
DK - Danimarca 30
AT - Austria 29
FI - Finlandia 25
BR - Brasile 23
FR - Francia 21
VN - Vietnam 21
TR - Turchia 15
BE - Belgio 13
CO - Colombia 12
NL - Olanda 10
CZ - Repubblica Ceca 6
IR - Iran 6
PL - Polonia 5
CL - Cile 4
EU - Europa 4
CH - Svizzera 3
JP - Giappone 3
PH - Filippine 3
AU - Australia 2
EC - Ecuador 2
GR - Grecia 2
NZ - Nuova Zelanda 2
PK - Pakistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AL - Albania 1
AM - Armenia 1
AR - Argentina 1
AZ - Azerbaigian 1
EE - Estonia 1
ES - Italia 1
IQ - Iraq 1
JM - Giamaica 1
LA - Repubblica Popolare Democratica del Laos 1
LT - Lituania 1
RO - Romania 1
SA - Arabia Saudita 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 5.027
Città #
Ann Arbor 894
Frankfurt am Main 245
Chandler 244
Fairfield 225
Dublin 200
Singapore 186
Wilmington 146
New York 116
Woodbridge 111
Ashburn 109
Houston 107
Seattle 86
Hong Kong 71
Cambridge 70
Princeton 70
Santa Clara 62
Milan 59
Jacksonville 48
Jakarta 43
Altamura 37
Dearborn 36
Lawrence 32
Vienna 27
Shanghai 26
Nanjing 19
Pune 19
Guangzhou 18
London 18
Andover 17
Fremont 17
Boardman 15
Dong Ket 14
Ottawa 13
Brussels 12
Helsinki 12
Rome 12
San Diego 12
Bogotá 10
Los Angeles 10
Lachine 9
Falls Church 8
Shenyang 8
Busto Arsizio 7
Changsha 7
Hebei 7
Lissone 7
Toronto 7
Nanchang 6
Beijing 5
Bresso 5
Brno 5
Dallas 5
Edmonton 5
Florence 5
Jinan 5
Kiev 5
Monza 5
Palermo 5
Rovereto 5
Turin 5
Washington 5
Brescia 4
Enterprise 4
Munich 4
Ningbo 4
Paris 4
Polska 4
Amsterdam 3
Carate Brianza 3
Catania 3
Chicago 3
Hangzhou 3
Hanoi 3
Kocaeli 3
Maastricht 3
Melzo 3
North York 3
Romola 3
Santiago 3
Shenzhen 3
Stockholm 3
Taizhou 3
Weimar 3
Albano Sant'Alessandro 2
Altamonte Springs 2
Auckland 2
Bangalore 2
Bari 2
Bergamo 2
Bhubaneswar 2
Broni 2
Catterick 2
Ceva 2
Changchun 2
Chelyabinsk 2
Chengdu 2
Chennai 2
Chennevières-sur-marne 2
Chiswick 2
Cinisello Balsamo 2
Totale 3.705
Nome #
Feasibility and physiological effects of prone positioning in non-intubated patients with acute respiratory failure due to COVID-19 (PRON-COVID): a prospective cohort study 343
Similar success rates but lower incidence of telaprevir-related rash in HIV/HCV coinfected as compared to HCV-monoinfected patients treated with triple anti-HCV therapy 234
Risk of chronic kidney disease among patients developing mild renal impairment during tenofovir-containing antiretroviral treatment 223
Helmet CPAP to treat hypoxic pneumonia outside the ICU: an observational study during the COVID-19 outbreak 222
Prospective immune dynamics during the first 24 weeks of efavirenz based-antiretroviral therapy in HIV-1-infected subjects, according to CD4+ T-cell counts at presentation: The IMMUNEF clinical trial 218
Remdesivir use in patients requiring mechanical ventilation due to COVID-19 216
Caratteristiche di una coorte di pazienti con co-infezione HIV/HCV: i dati dell’Ambulatorio di Malattie Infettive dell’Ospedale San Gerardo di Monza 202
The high volume of patients admitted during the SARS-CoV-2 pandemic has an independent harmful impact on in-hospital mortality from COVID-19 202
HIV testing: A must for patients with inflammatory bowel disease 198
A case of cerebrospinal fluid viral escape on a dual antiretroviral regimen: Worth the risk? 185
A case of classic neuromyelitis optica (Devic's syndrome) triggered by pegylated-interferon α 177
High rates of 30-day mortality in patients with cirrhosis and COVID-19 174
HPV 16 and 18 contribute to development of anal dysplasia in HIV infection irrespective of gender and sexual orientation 174
Comparison of three therapeutic regimens for genotype-3 hepatitis C virus infection in a large real-life multicentre cohort 172
Unmasking tuberculosis in the era of antiretroviral treatment 167
Evaluation of adhesion molecules and immune parameters in HIV-infected patients treated with an atazanavir/ritonavir- compared with a lopinavir/ritonavir-based regimen 165
KIR-HLA genotypes in HIV-infected patients lacking immunological recovery despite effective antiretroviral therapy 163
Lung cryptococcosis in a treated HIV-1-infected patient with suppressed viral load and past disseminated cryptococcosis: Relapse or late IRIS? 163
Real-life effectiveness and safety of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients with previous DAA failure 161
miRNA Expression Profiling in Subcutaneous Adipose Tissue of Monozygotic Twins Discordant for HIV Infection: Validation of Differentially Expressed miRNA and Bioinformatic Analysis 129
Real-world effectiveness and safety of glecaprevir/pibrentasvir in 723 patients with chronic hepatitis C 127
Beware of biases in observational studies on anti-spike monoclonal antibodies 116
COVID-19 Mortality and Stress to the Hospital System From High Patient Load 104
Malassorbimento intestinale della terapia antiretrovirale in un paziente affetto da AIDS e micobatteriosi atipica disseminata 101
Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data 100
Reply to: Correspondence on “High rates of 30-day mortality in patients with cirrhosis and COVID-19” 80
Ruolo delle strutture ambulatoriali extra-ospedaliere per pazienti con COVID-19: l’esperienza dell’Hotspot COVID di Monza. Role of outpatient facilities for patients with COVID-19: the experience of the COVID Hotspot in Monza. 78
Pharmacotherapy of HIV: Focus on Etravirine 74
Unmasked tuberculosis or lymphoma in late AIDS presenters: A difficult differential diagnosis 69
Imported ciprofloxacin-resistant Neisseria meningitidis 66
Behavioural survey and street-based HIV and HCV rapid testing programme among transgender sex workers 64
Unexpected viral relapses in hepatitis C virus–infected patients diagnosed with hepatocellular carcinoma during treatment with direct-acting antivirals 63
High rates of sustained virological response despite premature discontinuation of directly acting antivirals in HCV-infected patients treated in a real-life setting 54
Monotherapy with lopinavir/ritonavir versus standard of care in HIV-infected patients virologically suppressed while on treatment with protease inhibitor-based regimens: results from the MoLo study 53
Safety and efficacy of daclatasvir at doses other than 60 mg daily in HIV/HCV co-infected subjects: Data from the ICONA/HepaICONA foundation cohorts 50
Dysmetabolism, Diabetes and Clinical Outcomes in Patients Cured of Chronic Hepatitis C: A Real-Life Cohort Study 49
Influence of efavirenz and 8-hydroxy-efavirenz plasma levels on cognition and central nervous system side effects 43
Regaining virological suppression in a woman living with a six-class resistant HIV by combining injectable antiretroviral drugs guided by genotypic and phenotypic tests 38
COVID-19 Infection among Incarcerated Individuals and Prison Staff in Lombardy, Italy, March 2020 to February 2021 33
Do we Still Need Eligibility Criteria to Recommend PrEP? Impact of National Prescribing Requirements on Retention in Care and Sexually Transmitted Infections Acquisition 24
Reply 12
Reply 6
Occupational HIV infection in a research laboratory with unknown mode of transmission: a case report 3
Totale 5.295
Categoria #
all - tutte 20.215
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.215


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020332 0 0 0 0 0 49 46 32 62 47 53 43
2020/20211.042 37 49 70 120 120 90 73 100 93 109 63 118
2021/2022777 89 95 125 80 33 73 8 33 18 59 60 104
2022/20231.042 107 310 106 97 52 151 17 74 63 9 38 18
2023/2024711 26 18 30 24 100 222 126 34 36 19 8 68
2024/2025713 84 189 128 79 155 78 0 0 0 0 0 0
Totale 5.295